Abstract
Metabotropic glutamate (mGlu) receptors, which include mGlu1–8 receptors, are a heterogeneous family of G-protein-coupled receptors which function to modulate brain excitability via presynaptic, postsynaptic and glial mechanisms. Certain members of this receptor family have been shown to function as presynaptic regulatory mechanisms to control release of neurotransmitters. In general, Gi-coupled mGlu receptor subtypes appear to negatively modulate excitatory (and possibly also inhibitory) neurotransmitter output when activated. Localization studies have shown that mGlu7 is restricted to the presynaptic grid at the site of vesicle fusion. These studies along with other evidence suggest that mGlu7 is the nerve terminal autoreceptor that regulates physiological release of glutamate. Other mGlu subtypes, in particular mGlu2, mGlu8, and possibly mGlu4, are also localized presynaptically, but at perisynaptic sites outside the active zone of neurotransmitter release. Gi-coupled mGlu receptors also may exist on presynaptic elements of neighboring γ-aminobutyric acid (GABA) neurons where they play a role in heterosynaptic suppressions of GABA release. This suggests that these receptors may have evolved to monitor glutamate that has “spilled” out of the synapse. Thus, they may serve as the brain's evolutionary mechanism to prevent pathological changes in neuronal excitability and thus maintain homeostasis. Recent progress on the molecular and pharmacological aspects of these presynaptic mGlu receptors is unveiling their functions and the therapeutic directions of agents designed for these novel glutamate receptor targets.
Footnotes
- Abbreviations:
- mGlu
- metabotropic glutamate
- GPCRs
- G-protein-coupled receptors
- CNS
- central nervous system
- GABA
- γ-aminobutyric acid
- EPSP
- excitatory postsynaptic potential
- MCPG
- α-methyl-carboxyphenylglycine
- 5HT
- serotonin
- l-AP4
- l-2-amino-4-phosphonobutyric acid
- 3,4-DCPG
- (S)3,4-dicarboxyphenyl glycine
- AMPA
- α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
- NMDA
- N-methyl-d-aspartate
- nRT
- thalamic reticular nucleus
- Received April 3, 2001.
- Accepted May 5, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|